Home
Webinar: Completion of the Pediatric Praziquantel Consortium’s pivotal Phase III trial
Join us as we celebrate a major achievement for the Pediatric Praziquantel Consortium: completion of the pivotal clinical Phase III trial of arpraziquantel – a potential new treatment option for the estimated 50 million preschool-aged children with schistosomiasis.